Oncology & Cancer

Prognosis of multiple myeloma has improved since 2000

For patients with multiple myeloma (MM), there has been an improvement in prognosis since 2000, but mortality still remains elevated, according to a study published online April 6 in BMC Cancer.

Oncology & Cancer

Combination therapy overcomes BET inhibitor resistance, shows study

Scientists at St. Jude Children's Research Hospital developed a novel combination therapy approach for a leukemia subtype harboring rearrangements in the KMT2A gene. The approach overcomes the cancer's drug resistance, without ...

Oncology & Cancer

Researchers leverage cell self-destruction to treat brain tumors

Glioblastoma is the most common type of brain tumor in adults. The disease is 100% fatal and there are no cures, making it the most aggressive type of cancer. Such a poor prognosis has motivated researchers and neurosurgeons ...

page 6 from 40